Bold ideas.
Big impact.

As company builders, we turn innovations into better outcomes for billions of people.

Investing in human health from ideation to patient care.

At Amplitude, we create, build, and grow precision medicine companies that make a difference in patients’ lives.

Portfolio
Exited
Exited

Focused on outcomes.

We are committed to the success of founders, patients, and our investors, and regularly partner with leading entrepreneurs to positively impact the patient journey. That commitment is evidenced by the combined track record of our people.

0
companies
scaled
0
approved
products
0 diseases
addressed
0 exits
1B+ patients
impacted

“I’ve worked with the Amplitude team for over a decade and have always appreciated their honesty, transparency, and willingness to connect me to other investors across the North American investment community. They’re good biotech people with strong domain expertise and are always ready to pitch in and help tactically and strategically.”

Paul Truex
Paul Truex
Chairman and CEO, Thryv

“Over our years working with the Amplitude team, we have always appreciated their unique and insightful perspective. They genuinely care about our business, ask smart questions, and always look for opportunities to make connections that drive our important work forward.”

Michael R. Hayden
Michael R. Hayden
CEO, Prilenia

“As a successful American biotech company, we had a lot of choices when it came to raising capital. We chose Amplitude — our only Canadian investor — because of their deep biotech experience and excellent reputation. They played a pivotal role on our board at every step along the way from the day they invested until the day we were acquired.”

Tariq Kassum
Tariq Kassum
CEO, Celsius Therapeutics

“Amplitude has been a long-time friend and thought partner, and were the first people I called when I started Ability. Not only were they our first investor, they’ve also been instrumental in helping us think through our strategy and raise the capital we need to grow the business.”

Giles Day
Giles Day
CEO, Ability Biotherapeutics

“I’ve known the Amplitude team for more than a decade and was eager to work with them again when I founded Congruence. Amplitude was our co-lead for the Series A and has been a thoughtful partner that has played an important role in helping us build our AI-powered protein folding platform.”

Clarissa Desjardins
Clarissa Desjardins
CEO, Congruence

“Amplitude has been a great partner. They are supportive in all the right ways, backing our company strategy and lending their expertise as needed. This is especially true during fundraising, usually one of the most challenging times for private company.”

Luis Peña
Luis Peña
President and CEO, Evommune

“The team at Amplitude are incredible partners. They made us think bigger, worked with us on our strategy, introduced us to the talent and advisors we needed, and ultimately helped us build a next-generation AI and biotech company.”

Daniel Cohen
Daniel Cohen
President, Valence Labs

“As one of our founding investors, Amplitude has been with us since the early days of the company and has played a critical role in our journey. They have been an active partner at every turn, supporting Abdera in each financing, and connecting us to important partners, investors, and key talent in the broader ecosystem.”

Lori Lyons-Williams
Lori Lyons-Williams
President and CEO, Abdera Therapeutics

More than just investors.

We’re also entrepreneurs and scientists who have been in your shoes. We value excellence, transparency, and integrity, and love partnering with passionate founders and innovators.

Team

Cultivating the next generation of leaders in precision medicine.

Every summer, the Amplitude Fellowship brings Canada’s brightest health-focused PhD candidates, post docs, and MDs together to explore “what if” biotech concepts as the first step in creating novel, life-changing health science companies.

Discover our program